2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34599981 | PAR2 blockade reverses osimertinib resistance in non-small-cell lung cancer cells via attenuating ERK-mediated EMT and PD-L1 expression. | 2022 Jan | 5 |
| 2 | 33504904 | Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients. | 2021 Jan 27 | 1 |